341 related articles for article (PubMed ID: 11401894)
1. Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis.
Clancy JP; Bebök Z; Ruiz F; King C; Jones J; Walker L; Greer H; Hong J; Wing L; Macaluso M; Lyrene R; Sorscher EJ; Bedwell DM
Am J Respir Crit Care Med; 2001 Jun; 163(7):1683-92. PubMed ID: 11401894
[TBL] [Abstract][Full Text] [Related]
2. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
[TBL] [Abstract][Full Text] [Related]
3. In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study.
Sermet-Gaudelus I; Renouil M; Fajac A; Bidou L; Parbaille B; Pierrot S; Davy N; Bismuth E; Reinert P; Lenoir G; Lesure JF; Rousset JP; Edelman A
BMC Med; 2007 Mar; 5():5. PubMed ID: 17394637
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations.
Wilschanski M; Famini C; Blau H; Rivlin J; Augarten A; Avital A; Kerem B; Kerem E
Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):860-5. PubMed ID: 10712334
[TBL] [Abstract][Full Text] [Related]
5. Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Sermet-Gaudelus I; Boeck KD; Casimir GJ; Vermeulen F; Leal T; Mogenet A; Roussel D; Fritsch J; Hanssens L; Hirawat S; Miller NL; Constantine S; Reha A; Ajayi T; Elfring GL; Miller LL
Am J Respir Crit Care Med; 2010 Nov; 182(10):1262-72. PubMed ID: 20622033
[TBL] [Abstract][Full Text] [Related]
6. No detectable improvements in cystic fibrosis transmembrane conductance regulator by nasal aminoglycosides in patients with cystic fibrosis with stop mutations.
Clancy JP; Rowe SM; Bebok Z; Aitken ML; Gibson R; Zeitlin P; Berclaz P; Moss R; Knowles MR; Oster RA; Mayer-Hamblett N; Ramsey B
Am J Respir Cell Mol Biol; 2007 Jul; 37(1):57-66. PubMed ID: 17347447
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial.
Kerem E; Hirawat S; Armoni S; Yaakov Y; Shoseyov D; Cohen M; Nissim-Rafinia M; Blau H; Rivlin J; Aviram M; Elfring GL; Northcutt VJ; Miller LL; Kerem B; Wilschanski M
Lancet; 2008 Aug; 372(9640):719-27. PubMed ID: 18722008
[TBL] [Abstract][Full Text] [Related]
8. Cystic fibrosis transmembrane conductance regulator channel dysfunction in non-cystic fibrosis bronchiectasis.
Bienvenu T; Sermet-Gaudelus I; Burgel PR; Hubert D; Crestani B; Bassinet L; Dusser D; Fajac I
Am J Respir Crit Care Med; 2010 May; 181(10):1078-84. PubMed ID: 20167849
[TBL] [Abstract][Full Text] [Related]
9. Relationship between airway ion transport and a mild pulmonary disease mutation in CFTR.
Walker LC; Venglarik CJ; Aubin G; Weatherly MR; McCarty NA; Lesnick B; Ruiz F; Clancy JP; Sorscher EJ
Am J Respir Crit Care Med; 1997 May; 155(5):1684-9. PubMed ID: 9154877
[TBL] [Abstract][Full Text] [Related]
10. Induction of a cAMP-stimulated chloride secretion in regenerating poorly differentiated airway epithelial cells by adenovirus-mediated CFTR gene transfer.
Dupuit F; Chinet T; Zahm JM; Pierrot D; Hinnrasky J; Kaplan H; Bonnet N; Puchelle E
Hum Gene Ther; 1997 Aug; 8(12):1439-50. PubMed ID: 9287144
[TBL] [Abstract][Full Text] [Related]
11. Aminoglycoside suppression of a premature stop mutation in a Cftr-/- mouse carrying a human CFTR-G542X transgene.
Du M; Jones JR; Lanier J; Keeling KM; Lindsey JR; Tousson A; Bebök Z; Whitsett JA; Dey CR; Colledge WH; Evans MJ; Sorscher EJ; Bedwell DM
J Mol Med (Berl); 2002 Sep; 80(9):595-604. PubMed ID: 12226741
[TBL] [Abstract][Full Text] [Related]
12. Quantitative fluorescence measurements of chloride secretion in native airway epithelium from CF and non-CF subjects.
Stern M; Munkonge FM; Caplen NJ; Sorgi F; Huang L; Geddes DM; Alton EW
Gene Ther; 1995 Dec; 2(10):766-74. PubMed ID: 8750017
[TBL] [Abstract][Full Text] [Related]
13. Measurement of nasal potential difference in young children with an equivocal sweat test following newborn screening for cystic fibrosis.
Sermet-Gaudelus I; Girodon E; Roussel D; Deneuville E; Bui S; Huet F; Guillot M; Aboutaam R; Renouil M; Munck A; des Georges M; Iron A; Thauvin-Robinet C; Fajac I; Lenoir G; Roussey M; Edelman A
Thorax; 2010 Jun; 65(6):539-44. PubMed ID: 20522854
[TBL] [Abstract][Full Text] [Related]
14. Chloride transport in nasal ciliated cells of cystic fibrosis heterozygotes.
Sermet-Gaudelus I; Déchaux M; Vallée B; Fajac A; Girodon E; Nguyen-Khoa T; Marianovski R; Hurbain I; Bresson JL; Lenoir G; Edelman A
Am J Respir Crit Care Med; 2005 May; 171(9):1026-31. PubMed ID: 15709055
[TBL] [Abstract][Full Text] [Related]
15. The in vivo effects of milrinone on the airways of cystic fibrosis mice and human subjects.
Smith SN; Middleton PG; Chadwick S; Jaffe A; Bush KA; Rolleston S; Farley R; Delaney SJ; Wainwright B; Geddes DM; Alton EW
Am J Respir Cell Mol Biol; 1999 Jan; 20(1):129-34. PubMed ID: 9870926
[TBL] [Abstract][Full Text] [Related]
16. Normal function of the cystic fibrosis conductance regulator protein can be associated with homozygous (Delta)F508 mutation.
Sermet-Gaudelus I; Vallée B; Urbin I; Torossi T; Marianovski R; Fajac A; Feuillet MN; Bresson JL; Lenoir G; Bernaudin JF; Edelman A
Pediatr Res; 2002 Nov; 52(5):628-35. PubMed ID: 12409506
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis.
Gill DR; Southern KW; Mofford KA; Seddon T; Huang L; Sorgi F; Thomson A; MacVinish LJ; Ratcliff R; Bilton D; Lane DJ; Littlewood JM; Webb AK; Middleton PG; Colledge WH; Cuthbert AW; Evans MJ; Higgins CF; Hyde SC
Gene Ther; 1997 Mar; 4(3):199-209. PubMed ID: 9135733
[TBL] [Abstract][Full Text] [Related]
18. Nasal potential difference in congenital bilateral absence of the vas deferens.
Pradal U; Castellani C; Delmarco A; Mastella G
Am J Respir Crit Care Med; 1998 Sep; 158(3):896-901. PubMed ID: 9731023
[TBL] [Abstract][Full Text] [Related]
19. Intestinal current measurement for diagnostic classification of patients with questionable cystic fibrosis: validation and reference data.
Derichs N; Sanz J; Von Kanel T; Stolpe C; Zapf A; Tümmler B; Gallati S; Ballmann M
Thorax; 2010 Jul; 65(7):594-9. PubMed ID: 20627915
[TBL] [Abstract][Full Text] [Related]
20. CFTR genotype and clinical outcomes of adult patients carried as cystic fibrosis disease.
Bonadia LC; de Lima Marson FA; Ribeiro JD; Paschoal IA; Pereira MC; Ribeiro AF; Bertuzzo CS
Gene; 2014 May; 540(2):183-90. PubMed ID: 24583165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
